Article

FlexMD to distribute tear test in southeastern U.S.

Raleigh, NC-FlexMD, a distributor of dry eye diagnostics, will exclusively distribute the Touch Scientific Tear MicroAssay Test in the southeastern United States.

Related Videos
Anat Loewenstein comments on the recent FDA approval of revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2 treatment
Anat Loewenstein comments on the recent FDA approval of revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2 treatment
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbidities
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbidities
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
EnVision Summit 2025: Ergonomics in the operating room
EnVision Summit 2025: Ergonomics in the operating room
EnVision Summit 2025: Complications in glaucoma surgery
EnVision Summit 2025: Complications in glaucoma surgery
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
50 years in ophthalmology: Glaucoma advancements
50 years in ophthalmology: Glaucoma advancements
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
50 Years in Ophthalmology: A look at glaucoma treatments
50 Years in Ophthalmology: A look at glaucoma treatments
Related Content
Cyclosporine A eye drops ease ocular discomfort after cataract surgery
March 13th 2025

Cyclosporine A eye drops ease ocular discomfort after cataract surgery

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Tenpoint Therapeutics Ltd. appoints Carol Kearney as Chief Commercial Officer
March 12th 2025

Tenpoint Therapeutics Ltd. appoints Carol Kearney as Chief Commercial Officer

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

FDA accepts new drug application for low-dose atropine from Sydnexis
March 11th 2025

FDA accepts new drug application for low-dose atropine from Sydnexis

Kodiak Sciences completes enrollment in phase 3 GLOW2 trial of tarcocimab tedromer in patients with diabetic retinopathy
March 11th 2025

Kodiak Sciences completes enrollment in phase 3 GLOW2 trial of tarcocimab tedromer in patients with diabetic retinopathy

© 2025 MJH Life Sciences

All rights reserved.